Jennifer Dressman, Ph.D. (she/her/hers)

Fraunhofer Institute for Translational Medicine and Pharmacology, Germany

Poster(s):

• (M1030-01-03) A Case Study on the Applicability of the Refined Developability Classification System to Identify Compounds Suitable for Biowaivers: Voriconazole
  Monday, October 23, 2023

  10:30 AM – 11:30 AM ET

• (M0930-11-70) A Comparative Study of In Vitro Itraconazole Drug Release from Amorphous Solid Dispersions (ASDs): Sempera® and Tolsura® under Fed State Conditions
  Monday, October 23, 2023

  9:30 AM – 10:30 AM ET

• (M1130-05-30) A Robust, Viable, and Resource Sparing HPLC-Based logP Method Applied to Common Drugs
  Monday, October 23, 2023

  11:30 AM – 12:30 PM ET

• (M1430-08-49) An In Vitro Model for Acetaminophen Dissolution from Overdosed Oral Formulations
  Monday, October 23, 2023

  2:30 PM – 3:30 PM ET

• (T1130-11-73) Influence of Drug Load and Surfactant Concentration on the Release Performance of Ternary Amorphous Solid Dispersions
  Tuesday, October 24, 2023

  11:30 AM – 12:30 PM ET

• (W0930-09-57) New Insights into Non-classical Crystallization of Pharmaceutical Solids: Chemically-Specific Coherent Raman Imaging of Liquid-Liquid Phase Separation
  Wednesday, October 25, 2023

  9:30 AM – 10:30 AM ET

• (M1230-10-64) PBPK Modeling Coupled with Biorelevant Dissolution to Forecast the Oral Performance of Amorphous Solid Dispersion Formulations
  Monday, October 23, 2023

  12:30 PM – 1:30 PM ET

• (T1430-11-75) Suitability of Isavuconazonium Sulfate as a Biopharmaceutics Classification System (BCS)-Based Biowaiver Candidate
  Tuesday, October 24, 2023

  2:30 PM – 3:30 PM ET